Day: December 23, 2024

FOXO TECHNOLOGIES INC. ANOUNCES DETAILS OF ITS 2024 ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON DECEMBER 31, 2024

Written by Customer Service on December 23, 2024. Posted in Public Companies.

MINNEAPOLIS, MN, Dec. 23, 2024 (GLOBE NEWSWIRE) — FOXO Technologies Inc. (NYSE American: FOXO) (the “Company” or “FOXO”), will hold its 2024 Annual General Meeting of its Shareholders at 9:30 am CST on Tuesday, December 31, 2024. The Annual General Meeting will be a completely virtual meeting of its stockholders, which will be conducted via live webcast. You will be able to attend the Annual Meeting online, vote and submit your questions during the Annual Meeting by first registering at https://web.viewproxy.com/FOXO/2024 Shareholders of record on December 19, 2024, will be entitled to vote on the proposals. All shareholder votes are important. The Board of Directors asks that all shareholders vote in favor of the proposals listed on the Proxy Card filed as part of the Definitive Proxy Statement filed with the Securities and Exchange...

Sonnet BioTherapeutics Announces Release of the Next CEO Corner Segment

Written by Customer Service on December 23, 2024. Posted in Public Companies.

PRINCETON, NJ, Dec. 23, 2024 (GLOBE NEWSWIRE) — Sonnet BioTherapeutics Holdings, Inc. (the “Company” or “Sonnet”) (NASDAQ: SONN), a clinical-stage company developing targeted immunotherapeutic drugs, today announced the next CEO Corner segment has been published on the Company’s website. As part of the CEO Corner segment, Pankaj Mohan, Ph.D., Founder and Chief Executive Officer of Sonnet, highlighted the Company’s key accomplishments for calendar year 2024 and the targeted value-driving milestones in calendar year 2025. The CEO Corner is now accessible on the Company’s website here. Segments on the CEO Corner platform will be accessible on the Company’s website (www.sonnetbio.com) for 90 days. About Sonnet BioTherapeutics Holdings, Inc. Sonnet BioTherapeutics is an oncology-focused biotechnology company with a proprietary platform...

Singular Genomics Enters into Agreement to be Acquired by Deerfield for $20.00 in Cash per Share

Written by Customer Service on December 23, 2024. Posted in Mergers And Acquisitions.

SAN DIEGO, Dec. 23, 2024 (GLOBE NEWSWIRE) — Singular Genomics Systems, Inc. (Nasdaq: OMIC) (“Singular Genomics” or the “Company”), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to empower researchers and clinicians, today announced that it has entered into a definitive merger agreement whereby an affiliate of Deerfield Management Company, L.P. will acquire Singular Genomics in an all-cash transaction for $20.00 per share. The $20.00 per share represents 254% premium to the last closing share price for Singular’s common stock prior to the September 12, 2024 public disclosure of Deerfield’s initial acquisition proposal. The Singular Genomics Board of Directors formed a special committee composed entirely of independent and disinterested directors (the “Special Committee”) to evaluate...

Ikena Oncology and Inmagene Biopharmaceuticals Announce Agreement for Merger and Private Placement

Written by Customer Service on December 23, 2024. Posted in Mergers And Acquisitions.

Inmagene Biopharmaceuticals is a clinical stage company focused on developing IMG-007, a non-depleting anti-OX40 monoclonal antibody with an extended half-life and a silenced ADCC function The transaction is expected to result in approximately $175 million to support further development of IMG-007, including $75 million from an oversubscribed Private Placement that will close immediately following the merger The Financing includes both new investors such as Deep Track Capital, Foresite Capital, RTW Investments, and existing Ikena investors such as BVF Partners L.P., Blue Owl Healthcare Opportunities, Omega Funds, and OrbiMed The transaction is expected to close in mid-2025 BOSTON and SAN DIEGO, Dec. 23, 2024 (GLOBE NEWSWIRE) — Ikena Oncology, Inc. (Nasdaq: IKNA, “Ikena,”) and Inmagene Biopharmaceuticals (“Inmagene”) announced they...

FlexShopper Announces Record Initial Holiday Season Results

Written by Customer Service on December 23, 2024. Posted in Earnings Releases And Operating Results.

Robust October and November 2024 results driven by the continued success of FlexShopper’s direct-to-consumer and business-to-business growth strategies Based on strong October and November 2024 performance, management expects the fourth quarter of 2024 to exceed financial results for the fourth quarter of 2023 BOCA RATON, Fla., Dec. 23, 2024 (GLOBE NEWSWIRE) — FlexShopper, Inc. (Nasdaq: FPAY), a prominent national online lease-to-own retailer and payment solutions provider, today announced record initial holiday season financial results, as the Company benefits from the continued success of its direct-to-consumer (DTC) and business-to-business (B2B) growth strategies. For the first two months of the 2024 fourth quarter, compared to the same two-month period in 2023, lease gross revenue increased 15%, and lease net revenue increased...

Crazy Woman Creek Bancorp Reports Earnings for Fiscal Year 2024; Declares Annual Cash Dividend of $0.32 Per Share

Written by Customer Service on December 23, 2024. Posted in Public Companies.

BUFFALO, Wyo., Dec. 23, 2024 (GLOBE NEWSWIRE) — We continue to build our franchise as Crazy Woman Creek Bancorp (OTCPink: CRZY) and Buffalo Federal Bank, known as The Banks of Buffalo, Sheridan, Gillette and BFSB Mortgage of Evanston. Headquartered in Buffalo, Wyoming, our bank remains a vital business and community partner since founding in 1936. We take great pride in meeting our customers’ banking needs with a passion for local decision-making and personal involvement in our communities. Our vision remains to be the premier community bank serving the needs of individuals, families and businesses throughout North-Central Wyoming. Given our commitment to shareholders, we have declared an annual cash dividend of $0.32 per share to be paid in January 2025. Crazy Woman Creek Bancorp is proud to have posted the second-best performance...

GRI Bio Announces European Patent Office Issued a Decision to Grant Notice for Patent Covering GRI-0803 and Its Library of 500+ Proprietary Compounds

Written by Customer Service on December 23, 2024. Posted in Public Companies.

– Company committed to building a robust global patent estate across its innovative pipeline of NKT cell modulators LA JOLLA, CA, Dec. 23, 2024 (GLOBE NEWSWIRE) — GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (“NKT”) cell modulators for the treatment of inflammatory, fibrotic and autoimmune diseases, today announced that European Patent Office (EPO) has issued a decision to grant notice for patent application number 19,166,502 titled, “Oxygenated Amino- or Ammonium-Containing Sulfonic Acid, Phosphonic Acid and Carboxylic Acid Derivatives and Their Medical Use.” Based on the intention to grant notice, the Company expects the EPO to issue a patent January 16, 2025. “We have continued to make encouraging progress in our initiative to bolster our...

Kura Sushi USA to Announce Fiscal First Quarter 2025 Financial Results on January 7, 2025

Written by Customer Service on December 23, 2024. Posted in Public Companies.

IRVINE, Calif., Dec. 23, 2024 (GLOBE NEWSWIRE) — Kura Sushi USA, Inc. (“Kura Sushi” or the “Company”), (NASDAQ: KRUS), a technology-enabled Japanese restaurant concept, today announced that it will host a conference call to discuss fiscal first quarter 2025 financial results on Tuesday, January 7, 2025 at 5:00 p.m. ET. A press release with fiscal first quarter 2025 financial results will be issued that same day after the market closes. Hosting the conference call and webcast will be Hajime “Jimmy” Uba, President and Chief Executive Officer, Jeff Uttz, Chief Financial Officer, and Benjamin Porten, SVP Investor Relations & System Development. Interested parties may listen to the conference call via telephone by dialing 201-689-8471. A telephone replay will be available shortly after the call has concluded and can be accessed...

Borqs Technologies Reports Half-Year 2024 Financial Results; Successfully Increases Efficiency

Written by Customer Service on December 23, 2024. Posted in Public Companies.

SANTA CLARA, Calif., Dec. 23, 2024 (GLOBE NEWSWIRE) — Borqs Technologies, Inc. (U.S. OTC: BRQSF, “Borqs” or the “Company”), a global provider of embedded software and products for the Internet of Things (IoT), today announced its financial results for the first half of 2024. Interim financial statements were filed today with the SEC. First-Half 2024 Financial Highlights For the six months ended June 30, 2024 2023 vs. H1 2023 Revenues ($K) 16,773 14,992 + 11.9%Gross Margin 20.2% 19.4% Up 0.8%Operating expenses ($K) 7,082 11,996 – 41.0%Net income (loss) from operations 15,023 -28,801 n/a For the six months ended June 30, 2024, Borqs reported total net revenues of US$16.77 million, reflecting an increase from US$14.99 million in the same period of 2023, an increase of 11.9%,...

PIMCO Canada Announces Closing of the Mergers of Certain Closed-end Funds

Written by Customer Service on December 23, 2024. Posted in Mergers And Acquisitions.

TORONTO, Dec. 23, 2024 (GLOBE NEWSWIRE) — PIMCO Canada Corp. (“PIMCO Canada”) is pleased to announce that the previously announced reorganization of PIMCO Tactical Income Fund (TSX: PTI.UN), PIMCO Tactical Income Opportunities Fund (TSX: PTO.UN) and PIMCO Multi-Sector Income Fund (TSX: PIX.UN) (collectively, the “Funds”) with PIMCO Monthly Enhanced Income Fund (“PMEI”) (the “Mergers”) was completed following the close of business on December 20, 2024. Pursuant to the Mergers, PMEI acquired all of the outstanding units of each Fund in exchange for Class A units (the “PMEI Units”) of PMEI. Each unitholder of each Fund received, as of the close of business on December 20, 2024, such number of PMEI Units as is equal to the number of units of the applicable Fund held multiplied by the exchange ratio noted in the table below (the “Exchange...

Day: December 23, 2024

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals